文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT中前列腺癌肝转移的非典型表现

Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
PubMed 文献 · Clin Nucl Med · 2023-10-05

本文报告一例88岁男性组织学证实的转移性去势抵抗性前列腺癌患者,68Ga-PSMA-11 PET/CT显示广泛PSMA阴性肝转移。肝转移在68Ga-PSMA-11 PET/CT中通常表现为局灶性示踪剂摄取增高,而本例肝摄取减低,可能类似原发性肝肿瘤。

要点

  • 68Ga-PSMA-11 PET/CT在前列腺癌分期中具有重要临床价值,淋巴结和骨为最常见转移部位。
  • 肝转移罕见,通常表现为68Ga-PSMA-11局灶性摄取增高。
  • 本例88岁转移性去势抵抗性前列腺癌患者显示广泛PSMA阴性肝转移,肝摄取减低,可能类似原发性肝肿瘤。

核心结论

  • 68Ga-PSMA-11 PET/CT显示广泛PSMA阴性肝转移,肝摄取减低,可能类似原发性肝肿瘤,为前列腺癌肝转移的非典型表现。

研究设计与样本

  • 本文为病例报告,报告一例88岁男性组织学证实的转移性去势抵抗性前列腺癌患者。

主要发现

  • 68Ga-PSMA-11 PET/CT显示广泛PSMA阴性肝转移,肝摄取减低,可能类似原发性肝肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

68Ga-PSMA-11 (68Ga-prostate-specific membrane antigen-11) PET/CT continues to have a great clinical value for staging in prostate cancer. Lymph nodes and bone are the most typical metastatic sites of prostate cancer, whereas liver metastases are rare and usually show focally increased tracer uptake in 68Ga-PSMA-11 PET/CT. Here, we present an 88-year-old man with histologically proven metastatic castration-resistant prostate cancer and extensive PSMA-negative liver metastases identified by 68Ga-PSMA-11 PET/CT. This finding is remarkable because the decreased liver uptake of 68Ga-PSMA-11 may resemble a primary hepatic tumor.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Stanzel S, Weitzer F, Janek E, et al. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2023. PMID: 37934704. doi:10.1097/RLU.0000000000004898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。